<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The implantable cardioverter defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) is the gold standard therapy to prevent life-threatening <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Phobic <z:hpo ids='HP_0000739'>anxiety</z:hpo> predicts <z:hpo ids='HP_0004308'>ventricular arrhythmia</z:hpo> in <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> patients, but little is known about phobic <z:hpo ids='HP_0000739'>anxiety</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> patients </plain></SENT>
<SENT sid="2" pm="."><plain>This study aimed to identify determinants and the course of phobic <z:hpo ids='HP_0000739'>anxiety</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> patients </plain></SENT>
<SENT sid="3" pm="."><plain>PATIENTS: 140 outpatients living with an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> (mean age 56±14 years, 66% men) </plain></SENT>
<SENT sid="4" pm="."><plain>MAIN OUTCOME MEASURES: Phobic <z:hpo ids='HP_0000739'>anxiety</z:hpo> was assessed with the Symptom Checklist-90 Revised at a mean of 27±21 months (range 3-109) post-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> placement (baseline) and after an average follow-up of 41±18 months (range 10-82) </plain></SENT>
<SENT sid="5" pm="."><plain>Multivariate linear regression models considered sociodemographic factors, clinical variables and psychological scales as potential determinants of phobic <z:hpo ids='HP_0000739'>anxiety</z:hpo> scores </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> patients reported more than 10-fold higher levels of phobic <z:hpo ids='HP_0000739'>anxiety</z:hpo> than a previous representative population survey (2.6±3.4 vs 0.2±0.4) </plain></SENT>
<SENT sid="7" pm="."><plain>Greater age (p=0.003), previous shock experience (p=0.007), depressed mood (p&lt;0.001) and <z:e sem="disease" ids="C0020604" disease_type="Mental or Behavioral Dysfunction" abbrv="">hypochondriasis</z:e> (p=0.005) were associated with higher phobic <z:hpo ids='HP_0000739'>anxiety</z:hpo> scores at baseline </plain></SENT>
<SENT sid="8" pm="."><plain>Multimorbidity (p=0.030) and higher baseline phobic <z:hpo ids='HP_0000739'>anxiety</z:hpo> (p&lt;0.001) determined greater phobic <z:hpo ids='HP_0000739'>anxiety</z:hpo> at follow-up </plain></SENT>
<SENT sid="9" pm="."><plain>Younger age (p=0.029) and an elevated number of non-<z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac diseases</z:e> (p=0.019) were both associated with an increase in phobic <z:hpo ids='HP_0000739'>anxiety</z:hpo> scores from baseline to follow-up </plain></SENT>
<SENT sid="10" pm="."><plain>More patients had high phobic <z:hpo ids='HP_0000739'>anxiety</z:hpo> levels (score &gt;4) at follow-up compared with baseline (31% vs 24%; p=0.048) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Phobic <z:hpo ids='HP_0000739'>anxiety</z:hpo> was comparably high and persisted over time in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> patients </plain></SENT>
<SENT sid="12" pm="."><plain>Modifiable determinants of phobic <z:hpo ids='HP_0000739'>anxiety</z:hpo> were identified, which may inform tailored interventions to improve <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> patients' distress and perhaps also prognosis </plain></SENT>
</text></document>